In addition, the number of immune cells with antitumor ability dropped sharply in the high-risk group, specifically CD8+ and CD4+ T cells, which can recognize and kill tumor cells and can also produce various cytokines and chemokines to guide other immune cells to attack tumors [40, 41]. This evidence concerns the gene CD4 and neoplasm.